NorWest Mobile Diabetes and Kidney Screening and Intervention Project. Cindy Peters Primary Care Nurse

Size: px
Start display at page:

Download "NorWest Mobile Diabetes and Kidney Screening and Intervention Project. Cindy Peters Primary Care Nurse"

Transcription

1 NorWest Mobile Diabetes and Kidney Screening and Intervention Project Cindy Peters Primary Care Nurse

2 Interprofessional and Intersectoral partnerships

3 Aims of FINISHED (First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis) Partnership between the Diabetes Integration Project and Manitoba Renal Program Goal: To improve the health of First Nations communities though screening and treatment of kidney disease to prevent kidney failure requiring dialysis. 1. Screen for kidney disease in high risk, underserviced communities Instant, direct feedback to clients on level of risk 2. Refer clients at risk to appropriate treatments 3. Enter risk scores and information into the electronic Kidney Health record. 4. Use project results to convince MB Health and Health Canada that screening should be permanently funded

4 Aims of NorWest Project Through screen/triage/treat clinics identify: Individuals at risk for developing diabetes, hypertension or kidney disease Individuals with diabetes who may not have been screened for complications 5 year kidney failure risk prediction To provide follow up to those with risk factors (connect to primary care/chronic disease team, primary care provider, specialty care, other supports)

5 Key Partners

6 Rapid testing = 6-12 min Point of Care Testing & Instant Risk Prediction Finger prick for blood and small urine sample egfr, Ca, PO4, T-CO2, Albumin, Urine ACR, HgbA1C Real time tablet-based data entry custom app for this project Equipment undergoes quality assurance process each day to ensure precision and accuracy Mobile Chemistry Analyzer A1C/ACR Analyzer

7 Rationale MB has among the highest rate of kidney failure in all of Canada Screening general population is not recommended Focus on hard to reach high risk population groups (targeted screening) Prevent dialysis (determine 5 year risk prediction) Increase access to supports (primary health care)

8 At the screen/triage/treat clinics we will Obtain informed consent, complete health questionnaire Measure blood pressure (6 readings) Finger prick blood sample Urine sample Results are available within about 15 minutes (usually will spend about minutes to complete entire process) Education provided based on results Classified according to kidney disease risk level (4 categories of risk) Letters sent to primary care provider if applicable (if blood sugar or blood pressure elevated or kidney risk score indicates requires follow up Referral made to nephrology(kidney specialist)depending on risk level

9 Screening Blood Pressure egfr, Ca, PO4, HCO3, albumin Urine ACR HbA1c Risk Prediction No Current Risk BP <160/90 egfr > 60 ACR = < 3.0 HgA1c <7% and No known DM Low Risk egfr <60 and 1-3% risk of kidney failure over 5 yr OR BP>160/90 OR HgA1c>7% OR 3.0 > ACR > 100 Intermediate Risk 3-10%risk of kidney failure over 5 yr OR 100 < ACR < 200 High Risk >10%/ 5 yr risk of kidney failure OR ACR > 200 Treatment Lifestyle counseling Diet and Exercise Treatment Lifestyle counseling Diet and exercise Letter to primary care practitioner Flag for yearly rescreening Treatment Lifestyle counseling Diet and exercise Arrange referral to MRP for evaluation by a nephrologist Treatment Lifestyle counseling Arrange urgent referral to the MRP for detailed evaluation by a nephrologist & team

10 Consent

11 Consent

12 Consent

13 Point of Care Testing blood pressure

14 Point of Care Testing blood and urine

15 Point of Care Testing

16 Education

17 Findings May 2015 July 2016 (total of 103 screening days) 430 community members screened: 219 First Nations, Inuit or Metis 65 Filipino 44 South Asian 102 Other ethnicities No risk 284 Low risk 137 Intermediate risk 5 High risk 3 81 referrals to attach to primary care provider 74 referrals to diabetes education 108 referrals to registered dietitian (194 for group education) 34 referrals for smoking cessation 67 referrals to foot care education 14 referrals to counseling supports

18 Demographic Characteristics of Screening Cohort Findings First Nations South Asian (n = 219) (n = 44) Filipino (n = 65) Other (n = 102) Age (years) 41 (13.6) 43.2 (15.6) 54.1 (13.8) 55.5 (15.9) Sex (% female) 64.8% 65.9% 53.9% 72.6% HgbA1C (% 6.5%) 14.2% 4.7% 24.6% 22.8% egfr (ml/min per 1.73 m 2 ) (42.6) (60.7) 98.3 (40.9) (37.2) egfr (ml/min per 1.73 m 2 ) (% < 60) Urine ACR (mg/mmol) 3.2% 2.3% 12.3% 6.9% 1.8 ( ) 1.9 ( ) 1.9 ( ) 1.9 ( ) Albuminuria (% 3 mg/mmol) 14.2% 4.7% 20.0% 18.6% Chronic Kidney Disease (egfr < 60 or Urine ACR > 16.0% 6.8% 24.6% 21.6% 3 mg/mmol) Elevated Blood Pressure ( 140 mmhg SBP or 90 mmhg DBP) Systolic BP (mmhg) 17.4% (14.2) 13.6% (16.8) 23.1% (19.1) 25.5% (21.6) Diastolic BP (mmhg) 78.4 (10) 75 (8.4) 77.5 (10.8) 76.9 (13.4) Kidney Failure Risk (Item S1) No Risk 67.0% 86.1% 55.0% 64.3% Low Risk 31.7% 14.0% 38.3% 33.7% Int. Risk 0.9% 0.0% 1.7% 2.0% High Risk 0.5% 0.0% 5.0% 0.0% Summary statistics given as mean ± SD for normally distributed variables, median (interquartile range) for non-normally distributed variables, and percentages (N) for categorical variables. Some categories may not sum to 100% due to rounding. HgbA1C: Glycated Hemoglobin, SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure. The criteria for determination of kidney failure risk are presented in Item S1.

19 Findings Further extrapolation of data from Manitoba Centre for Health Policy (MCHP) is underway Data analysis will be collated from a variety of databases including income, education, billing data, laboratory data as well as other social complexity measures Phase 2 focus on children, youth and families with risk factors

20 Training and Capacity Building 2 Project Leads 8 staff trained on operating procedures to run clinics Capacity Development Week provided by partners Collaboration of DIP and MRP training on use of POC equipment, operating procedures and community outreach Shadowing screening clinics in Rolling River First Nation, MB

21

22 Promotional pamphlets Community Engagement Strategy and Outreach Involvement of Community Development team, Indigenous outreach worker, Immigrant Settlement Program Presented at networks and advisories Community leaders Food Banks / Resource Centres Leaflets to MB housing residences Promoting to those working in community (EIA) WRHA Diabetes Network partners

23

24 Thank you to our Partners!

25 Thank you! Join Us

Key Elements in Managing Diabetes

Key Elements in Managing Diabetes Key Elements in Managing Diabetes Presentor Disclosure No conflicts of interest to disclose Presented by Susan Cotey, RN, CDE Lennon Diabetes Center Stephanie Tubbs Jones Health Center Cleveland Clinic

More information

Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy)

Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy) Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy) Patient information Oxford Kidney Unit If you have been told you have chronic kidney disease (CKD) due to diabetic nephropathy this leaflet

More information

CKD and risk management : NICE guideline

CKD and risk management : NICE guideline CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of

More information

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease

More information

CHI Franciscan. Matt Levi Director Virtual Health Services. March 31, 2015

CHI Franciscan. Matt Levi Director Virtual Health Services. March 31, 2015 CHI Franciscan Matt Levi Director Virtual Health Services March 31, 2015 Reflection / 2 Agenda Introduction and background Matt Levi Director of Franciscan Health System Virtual Health Katie Farrell Manager

More information

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression CKDinform: A PCP s Guide to CKD Detection and Delaying Progression Learning Objectives Describe suitable screening tools, such as GFR and ACR, for proper utilization in clinical practice related to the

More information

ADVANCE post trial ObservatioNal Study

ADVANCE post trial ObservatioNal Study Hot Topics in Diabetes 50 th EASD, Vienna 2014 ADVANCE post trial ObservatioNal Study Sophia Zoungas The George Institute The University of Sydney Rationale and Study Design Sophia Zoungas The George Institute

More information

2016 Community Service Plan & Community Health Improvement Plan

2016 Community Service Plan & Community Health Improvement Plan 2016 Community Service Plan & Community Health Improvement Plan A.O. Fox Memorial Hospital The Mary Imogene Bassett Hospital (dba: Bassett Medical Center) & Otsego County Health Department Service Area:

More information

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies

More information

Nephrology referral - Does my patient need it? Disclosure

Nephrology referral - Does my patient need it? Disclosure Nephrology referral - Does my patient need it? Sophia Chou, MD MSc March 10, 2018 Faculty: Sophia Chou Disclosure Relationships with commercial interest: None Potential conflict of interest: None 1 Objectives

More information

Descriptive Epidemiology of STBBIs in the Winnipeg Health Region

Descriptive Epidemiology of STBBIs in the Winnipeg Health Region Descriptive Epidemiology of STBBIs in the Winnipeg Health Region Pierre Plourde Souradet Shaw Debbie Nowicki Mandy Whitlock March 22, 211 Methods Case definitions and case reporting In Manitoba, all confirmed

More information

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018 Diabetes and Kidney Disease Kris Bentley Renal Nurse practitioner 2018 Aims Develop an understanding of Chronic Kidney Disease Understand how diabetes impacts on your kidneys Be able to recognise the risk

More information

Diabetes Management: Interventions Engaging Community Health Workers

Diabetes Management: Interventions Engaging Community Health Workers Diabetes Management: Interventions Engaging Community Health Workers Community Preventive Services Task Force Finding and Rationale Statement Ratified April 2017 Table of Contents Intervention Definition...

More information

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007

More information

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria 1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage

More information

HUDSON HEADWATERS HEALTH NETWORK THE ROAD TO DIABETES RECOGNITION

HUDSON HEADWATERS HEALTH NETWORK THE ROAD TO DIABETES RECOGNITION HUDSON HEADWATERS HEALTH NETWORK THE ROAD TO DIABETES RECOGNITION Cyndi Nassivera-Cordes, RN, CRM October 4, 2010 WE DO ALL THAT Already involved with Diabetes Collaborative Adopted Evidence-Based Clinical

More information

Professor Suetonia Palmer

Professor Suetonia Palmer Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS

More information

A n aly tical m e t h o d s

A n aly tical m e t h o d s a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.

More information

KEEP 2.0 Annual Data Report Chapter Five

KEEP 2.0 Annual Data Report Chapter Five KEEP 2. Annual Data Report Chapter Five Figure 5.1 percent distribution of KEEP participants with elevated serum creatinine levels, overall & by age 16 Percent of participants 12 8 4 All

More information

year in review 2015/2016 manitoba renal program Winnipeg Regional Health Authority manitoba renal program

year in review 2015/2016 manitoba renal program Winnipeg Regional Health Authority manitoba renal program year in review 2015/2016 manitoba renal program Winnipeg Regional Health Authority manitoba renal program MANITOBA RENAL PROGRAM Manitoba Renal Program (MRP) is made up of an interdisciplinary team of

More information

Composite Performance Report

Composite Performance Report Composite Performance Report 10 9 91% 8 7 65% 68% 65% 6 56% 5 4 3 2 44% 37% 48% 31% 19% 29% 1 6% Key: Report Measure Name Cohort Target Cohort Definition Formula 1 Control Blood Pressure All patients who

More information

Quality ID #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

Quality ID #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care Quality ID #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Intermediate Outcome

More information

The future is here. It s just not widely distributed yet. William Gibson

The future is here. It s just not widely distributed yet. William Gibson The future is here. It s just not widely distributed yet. William Gibson CHRONIC KIDNEY DISEASE MANAGEMENT A NEW PARADIGM Aaron Cass, MD, FRCPC Nephrologist, Fraser Health January 22, 2014 Where Are We

More information

Chronic Disease Management Living Well with a Chronic Condition

Chronic Disease Management Living Well with a Chronic Condition Chronic Disease Management Living Well with a Chronic Condition 1 Goal of Living Well To enable as many people as possible with a chronic condition to better manage their conditions on their own and live

More information

The Health Problem: Guidelines: NHS Priority:

The Health Problem: Guidelines: NHS Priority: PRIORITY BRIEFING The purpose of this briefing paper is to aid Stakeholders in prioritising topics to be taken further by PenCLAHRC as the basis for a specific evaluation or implementation research project.

More information

Online clinical pathway for chronic kidney disease (CKD) in primary care. February 27, 2015 Dr. Kerry McBrien University of Calgary

Online clinical pathway for chronic kidney disease (CKD) in primary care. February 27, 2015 Dr. Kerry McBrien University of Calgary Online clinical pathway for chronic kidney disease (CKD) in primary care February 27, 2015 Dr. Kerry McBrien University of Calgary FACULTY/PRESENTER DISCLOSURE Faculty: Kerry McBrien Relationships with

More information

Interventions to reduce progression of CKD what is the evidence? John Feehally

Interventions to reduce progression of CKD what is the evidence? John Feehally Interventions to reduce progression of CKD what is the evidence? John Feehally Interventions to reduce progression of CKD what is the evidence? CHALLENGES Understanding what we know. NOT.what we think

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-1559. eequation. Applying the

More information

Integrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations. Dr Christina MAW Hospital Authority, Hong Kong

Integrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations. Dr Christina MAW Hospital Authority, Hong Kong Integrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations Dr Christina MAW Hospital Authority, Hong Kong Hospital Authority (HA) of Hong Kong A statutory body responsible

More information

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu Indicator area: Pulse rhythm assessment for AF Indicator: NM146 Date: June 2017 Introduction There is evidence

More information

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES UNIVERSITY OF CALGARY Quality of care and outcomes for First Nations People and non-first Nations People with diabetes mellitus by Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

Chapter Two Renal function measures in the adolescent NHANES population

Chapter Two Renal function measures in the adolescent NHANES population 0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you

More information

Blood Pressure Acre Surgery Diviash Thakrar

Blood Pressure Acre Surgery Diviash Thakrar Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise

More information

Office Management of Reduced GFR Practical advice for the management of CKD

Office Management of Reduced GFR Practical advice for the management of CKD Office Management of Reduced GFR Practical advice for the management of CKD CKD Online Education CME for Primary Care April 27, 2016 Monica Beaulieu, MD FRCPC MHA CHAIR PROVINCIAL KIDNEY CARE COMMITTEE

More information

Chapter 1: CKD in the General Population

Chapter 1: CKD in the General Population Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Quality ID #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:

More information

The Hypertension Clinic is a part of the Internal Medicine

The Hypertension Clinic is a part of the Internal Medicine Original Article Hypertension Registry at the Bangkok Hospital Medical Center: The First 7 Months Experience OBJECTIVE: The Hypertension Registry at the Bangkok Hospital Medical Center was established

More information

Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus

Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus 1 Contents Executive Summary... 3 How to Screen for Diabetic Nephropathy... 4 What to Measure... 4 Frequency

More information

Systolic Blood Pressure Intervention Trial (SPRINT)

Systolic Blood Pressure Intervention Trial (SPRINT) 09:30-09:50 2016.4.15 Systolic Blood Pressure Intervention Trial (SPRINT) IN A NEPHROLOGIST S VIEW Sejoong Kim Seoul National University Bundang Hospital Current guidelines for BP control Lowering BP

More information

Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea

Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease

More information

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

Department of Nephrology

Department of Nephrology OUTCOMES DIVISION OF MEDICINE Department of Nephrology About Cleveland Clinic Florida Cleveland Clinic Florida s medical staff are dedicated physicians who have joined the clinic as salaried doctors to

More information

Chronic Kidney Disease: Optimal and Coordinated Management

Chronic Kidney Disease: Optimal and Coordinated Management Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,

More information

Vascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme

Vascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme Vascular checks a vascular risk assessment and management Heather White Deputy Branch Head Vascular Programme Three Questions (1) What is the starting point? (2) Where are we now? (3) What happens next?

More information

CKD Prevention Program Protocol

CKD Prevention Program Protocol CKD Prevention Program Protocol Taiwan Pathway as an example I. Understanding problems and situations of ESRD/CKD in Taiwan 1. Understanding the ESRD/CKD Burden 1) National Dialysis Registry since 1987

More information

National Audit of CKD in Primary Care

National Audit of CKD in Primary Care National Audit of CKD in Primary Care David C Wheeler Royal Free Campus University College London d.wheeler@ucl.ac.uk Kidney for General Physicians RCP London 24 th November 2017 Who looks after CKD patients

More information

Manitoba Cervical Cancer Screening Program. Operations & Statistical Report and 2006

Manitoba Cervical Cancer Screening Program. Operations & Statistical Report and 2006 anitoba Cervical Cancer Screening Program Operations & Statistical Report 2005 and 2006 1 MCCSP 2005-2006 Report ANITOBA CERVICAL CANCER SCREENING PROGRAM 2005 and 2006 Operations & Statistical Report

More information

CKD at the primary and secondary care interface. Paul Cockwell Consultant Nephrologist Clinical Service Lead Renal Medicine, QEHB

CKD at the primary and secondary care interface. Paul Cockwell Consultant Nephrologist Clinical Service Lead Renal Medicine, QEHB CKD at the primary and secondary care interface Paul Cockwell Consultant Nephrologist Clinical Service Lead Renal Medicine, QEHB The Health improvement Network (THIN): 6.7 million patients from 426 primary

More information

Medication Therapy Management Solution

Medication Therapy Management Solution Medication Therapy Management Solution A Medicaid Case Report It s often challenging to include evidencebased clinical programs that offer financial benefits. However, pharmacotherapy is central to the

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

A NEW FOOD AND HEALTH PARTNERSHIP: COMMUNITY FOOD CENTRES CANADA AND NORWEST COOP COMMUNITY FOOD CENTRE

A NEW FOOD AND HEALTH PARTNERSHIP: COMMUNITY FOOD CENTRES CANADA AND NORWEST COOP COMMUNITY FOOD CENTRE A NEW FOOD AND HEALTH PARTNERSHIP: COMMUNITY FOOD CENTRES CANADA AND NORWEST COOP COMMUNITY FOOD CENTRE CFPC Conflict of Interest Presenter Disclosure Presenters: Linor David and Kristina McMillan Relationships

More information

Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions

Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions Andrew S Narva, MD Na/onal Kidney Disease Educa/on Program U.S. Department of Health and Human Services National Institute of

More information

May 2016 CTC/OHIC Measure Specifications

May 2016 CTC/OHIC Measure Specifications Active Patients: Overarching Principles and Definitions Out patients seen by a primary care clinician of the PCMH anytime within the last 24 months. Definition of primary care clinician includes the following:

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

Chronic kidney disease (CKD) has received

Chronic kidney disease (CKD) has received Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:

More information

Patient engagement and empowerment: Strategies to improve the chronic disease control among Ethnical Minority Patients in the primary care

Patient engagement and empowerment: Strategies to improve the chronic disease control among Ethnical Minority Patients in the primary care Patient engagement and empowerment: Strategies to improve the chronic disease control among Ethnical Minority Patients in the primary care Dr. Catherine Chen Dept. of FM and GOPC, KCC Background Hong Kong

More information

Adherence to Hypertension Visit Protocol Description: % of patients with HTN who are being monitored through follow up visits according to guidelines, based on "days since last BP", which looks back from

More information

The Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles

The Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles The Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles Linda M. Siminerio, RN, PhD, CDE Professor of Medicine University of Pittsburgh School of Medicine & Nursing Objectives

More information

CKD & HT. Anne-Marie Angus

CKD & HT. Anne-Marie Angus CKD & HT Anne-Marie Angus Hypertension definitions Persisting BP >140/90 and HBPM >135/85 Stage 1 >140/90 (HBPM >135/85) Stage 2 >160/100 (HBPM >150/90) Severe >180/100 White coat HT Why treat? A major

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community/Population Health Meaningful Measure Area: Preventive

More information

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Intermediate

More information

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

BASELINE CHARACTERISTICS OF THE STUDY POPULATION Study Summary DAILY ORAL SODIUM BICARBONATE PRESERVES GLOMERULAR FILTRATION RATE BY SLOWING ITS DECLINE IN EARLY HYPERTENSIVE NEPHROPATHY This was a 5-year, single-center, prospective, randomized, placebo-controlled,

More information

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON Story #1 CSHP 2015 objective Objective 2.1 - In 70% of ambulatory and specialized care clinics providing clinic care, pharmacists will manage medication therapy for clinic patients with complex and high-risk

More information

Nephrology. 3 rd Year Revision Session 06/05/17 Cathal Hannan

Nephrology. 3 rd Year Revision Session 06/05/17 Cathal Hannan Nephrology 3 rd Year Revision Session 06/05/17 Cathal Hannan Aims Acute Kidney Injury-recognition and management Sample OSCE Station Clinically relevant renal physiology Aetiology of Chronic Kidney Disease

More information

Preventive Cardiology

Preventive Cardiology Preventive Cardiology 21 Volume The Preventive Cardiology and Rehabilitation Prevention Outpatient Visits 7,876 Program helps patients identify traditional and Phase I Rehab 9,932 emerging nontraditional

More information

Playing the Game: Strategies For Completing the ACO Measures

Playing the Game: Strategies For Completing the ACO Measures ACO Quality Scoring Playing the Game: Strategies For Completing the ACO Measures June 2, 2016 1 2 Quality Measure Score Primary Focus on: GPRO (Group Practice Reporting Option) Measures >50% Preventative

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care

Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

When should you treat blood pressure in the young?

When should you treat blood pressure in the young? ESC Stockholm - Dilemmas in Cardiovascular Disease Prevention in the Young: 30 th August 2010 When should you treat blood pressure in the young? Bryan Williams MD FRCP FAHA FESC Professor of Medicine Department

More information

Chronic kidney disease screening and assessment

Chronic kidney disease screening and assessment Care map information Information resources for patients and carers Aboriginal and Torres Strait Islanders DEFINITION OF CKD egfr

More information

Stages of Chronic Kidney Disease (CKD)

Stages of Chronic Kidney Disease (CKD) Early Treatment is the Key Stages of Chronic Kidney Disease (CKD) Stage Description GFR (ml/min/1.73 m 2 ) >90 1 Kidney damage with normal or GFR 2 Mild decrease in GFR 60-89 3 Moderate decrease in GFR

More information

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Diabetes and Quality Measures.

Diabetes and Quality Measures. Diabetes and Quality Measures. Reducing Costs, Closing Gaps, and Improving Member Health Executive Summary According to the Centers for Disease Control, 29 million people in the U.S. have diabetes. Another

More information

PRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

PRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME PRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME 217 American Society of Nephrology Meeting Geoffrey A. Block 1, Pablo E. Pergola 2, Lesley

More information

Cardiovascular Disease Risk Prediction in Indigenous Australians

Cardiovascular Disease Risk Prediction in Indigenous Australians Cardiovascular Disease Risk Prediction in Indigenous Australians ELIZABETH LM BARR (MPH, PHD) NATIONAL HEART FOUNDATION POST-DOC FELLOW Cardiac Care in the NT Annual Workshop 2017 is proudly supported

More information

HEDIS QUICK REFERENCE GUIDE: DOCUMENTATION TIPS FOR ADULT MEASURES

HEDIS QUICK REFERENCE GUIDE: DOCUMENTATION TIPS FOR ADULT MEASURES HEDIS QUICK REFERENCE GUIDE: DOCUMENTATION TIPS FOR ADULT MEASURES For Health Care Providers January 2018 Helping you improve your scores, as you improve the health of your patients. Healthcare Effectiveness

More information

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2 Public Health Live T 2 B 2 Chronic Kidney Disease in Diabetes: Early Identification and Intervention Guest Speaker Joseph Vassalotti, MD, FASN Chief Medical Officer National Kidney Foundation Thanks to

More information

Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers

Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers Nada Abu-Kishk Health Nutrition Officer at UNRWA-HQ What is UNRWA (United Nations

More information

Management of early chronic kidney disease

Management of early chronic kidney disease Management of early chronic kidney disease GREENLANE SUMMER GP SYMPOSIUM 2018 Jonathan Hsiao Renal and General Physician Introduction A growing public health problem in NZ and throughout the world. Unknown

More information

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

Reframe the Paradigm of Hypertension treatment Focus on Diabetes Reframe the Paradigm of Hypertension treatment Focus on Diabetes Paola Atallah, MD Lecturer of Clinical Medicine SGUMC EDL monthly meeting October 25,2016 Overview Physiopathology of hypertension Classification

More information

KEEP Summary Figures S40. Am J Kidney Dis. 2012;59(3)(suppl 2):S40-S64

KEEP Summary Figures S40. Am J Kidney Dis. 2012;59(3)(suppl 2):S40-S64 211 Summary Figures S4 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 Definitions DATA ANALYSES DIABETES Self-reported diabetes, self reported diabetic retinopathy, receiving medication for diabetes, or elevated

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Five Years Outcome Review of IPCP Program for Newly Diagnosed Type II Diabetes (Family Medicine Diabetes Triage Clinic) in NTWC

Five Years Outcome Review of IPCP Program for Newly Diagnosed Type II Diabetes (Family Medicine Diabetes Triage Clinic) in NTWC Five Years Outcome Review of IPCP Program for Newly Diagnosed Type II Diabetes (Family Medicine Diabetes Triage Clinic) in NTWC Chan L, Liang J, Ho YY, Ng SY, Chow MF, Hung V, Ng S, Koo J, Choi P, Law

More information

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup http://www.kidney-international.org & 2013 DIGO Summary of Recommendation Statements idney International Supplements (2013) 3, 5 14; doi:10.1038/kisup.2012.77 Chapter 1: Definition and classification of

More information

KEEP Summary Figures S32. Am J Kidney Dis. 2011;57(3)(suppl 2):S32-S56

KEEP Summary Figures S32. Am J Kidney Dis. 2011;57(3)(suppl 2):S32-S56 21 Summary Figures S32 Definitions DATA ANALYSES DIABETES Self-reported diabetes, self reported diabetic retinopathy, receiving medication for diabetes, or elevated blood glucose (WHO); fasting blood sugar

More information

Diabetes Education and Outreach with the WVU Extension Service

Diabetes Education and Outreach with the WVU Extension Service Diabetes Education and Outreach with the WVU Extension Service David Roberts, WVU Extension Families and Health Agent Lincoln County Dana Wright, WVU Extension Families and Health Agent Logan County Extension

More information

HANS KAI: A community-led program that empowers people to take control of their own health

HANS KAI: A community-led program that empowers people to take control of their own health HANS KAI: A community-led program that empowers people to take control of their own health Presenter: Mike Sadlowski CES, Bkin, MSc Applied Ergonomics Health Promoter NorWest Co-op Community Health Centre

More information

Public Health Unit Tobacco Use Cessation Services

Public Health Unit Tobacco Use Cessation Services March 2017 Public Health Unit Tobacco Use Cessation Services Under the Ontario Public Health Standards, 1 Public Health Units (PHUs) are required to do a number of activities related to tobacco use cessation

More information

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members 2017 Diabetes Program Evaluation Our mission is to improve the health and quality of life of our members Diabetes Program Evaluation Program Title: Diabetes Program Evaluation Period: January 1, 2017 December

More information

Michigan s Diabetes Prevention and Control Program & National Kidney Foundation Michigan: A Successful Partnership

Michigan s Diabetes Prevention and Control Program & National Kidney Foundation Michigan: A Successful Partnership Michigan s Diabetes Prevention and Control Program & National Kidney Foundation Michigan: A Successful Partnership Dan Diepenhorst, MI DPCP diepenhorstd@michigan.gov Linda Smith-Wheelock, NKFM lsmith-wheelock@mkfm.org

More information

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group Repeat ischaemic heart disease audit of primary care patients (2002-2003): Comparisons by age, sex and ethnic group Baseline-repeat ischaemic heart disease audit of primary care patients: a comparison

More information

The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?

The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century? The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century? By: Baskar, WDHB, Renal Service Auckland New Zealand Presented at : 4 th International Conference on

More information

>4000 mg/dl (=20000/(500/100)) >615 mmol/l (=20000/(65*0.5))

>4000 mg/dl (=20000/(500/100)) >615 mmol/l (=20000/(65*0.5)) Supplemental Table 1 Thresholds to define outliers of lab values in screening test for proteinuria Type of screening test Unit Threshold for Outliers References 24 hour urine albumin mg/d >20000 experienced

More information